WEST CHESTER, Pa., Oct. 26, 2021 /PRNewswire/ -- Centinel Spine®, LLC, a leading global medical device company addressing cervical and lumbar spinal disease through anterior surgical access, today announced the recent publication...
For many attendees and exhibitors, Eurospine 2021 was the first face-to-face congress since before the coronavirus pandemic struck in March 2020. It was fantastic to meet up with friends and colleagues...
Whether your business is a start-up or an SME, and your key goal for 2022 is onboarding new distributors or attracting venture capital, we’re proud to provide our clients with an intelligent,...
Recent CE Mark Clearance Includes Reduction of Infection Claim SAN JOSE, Calif., Oct. 25, 2021 (GLOBE NEWSWIRE) -- Silver Bullet Therapeutics, Inc., a privately-held medical device company, announced today that it...
Melissa Paper, JD, MPA, CHC joins MCRA as Vice President of Healthcare Compliance WASHINGTON, Oct. 21, 2021 /PRNewswire/ -- MCRA, LLC, a leading medical device, in-vitro diagnostics, and biologics advisory firm and clinical...
Intellijoint VIEW provides orthopaedic surgeons with software enabling preoperative planning for total hip arthroplasty that doesn't require CT imaging and integrates with navigation. Canada, Oct. 21, 2021 (GLOBE NEWSWIRE) -- Kitchener,...
Berlin, 21 October 2021 aap Implantate AG (“aap” or the “Company”) has successfully completed the capital increase with subscription rights resolved on 27 September 2021. The order book both for placed...
Top Health Care Business and Policy Leaders Enhance Position as One of the Leading Health Care Private Equity Firms NEW YORK--(BUSINESS WIRE)--Consonance Capital Partners, a leading U.S.-based healthcare private equity firm,...
This broadens the OsteoCentric portfolio and expedites the proliferation of its patented UnifiMI technology into the pelvis. AUSTIN, Texas, Oct. 20, 2021 /PRNewswire/ -- OsteoCentric Technologies, a pioneer of bone fixation in the...
European venture capital firm has raised €1 billion in the last 12 months across its expanding life science investment platform. PARIS--(BUSINESS WIRE)--Sofinnova Partners, a leading European life sciences venture capital firm...